Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease

Abstract

Long-term kidney outcomes in patients with diabetic eye disease were similar in placebo and RBX groups. In conclusion, large-scale, prospective trials in patients with diabetic nephropathy are needed to confirm safety and potential benefits of RBX on clinical outcomes.